✦ LIBER ✦

Prophylactic heparin does not prevent liver veno-occlusive disease following autologous bone marrow transplantation

✍ Scribed by L. Marsa-Vila; N. C. Gorin; J. P. Laporte; M. Labopin; M. C. Dupuy-Montbrun; L. Fouillard; F. Isnard; A. Najman

Book ID: 114791517
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 853 KB
Volume: 47
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.1991.tb01859.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Veno-occlusive disease of the liver afte

Veno-occlusive disease of the liver after high-dose mitomycin C therapy and autologous bone marrow transplantation

✍ Hillard M. Lazarus; Marcia R. Gottfried; Roger H. Herzig; Gordon L. Phillips; Ro 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 710 KB

Transjugular intrahepatic portosystemic

Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation

✍ Azoulay, D; Castaing, D; Lemoine, A; Hargreaves, G M; Bismuth, H 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 58 KB

Veno-occlusive Disease of the Liver Foll

Veno-occlusive Disease of the Liver Following Bone Marrow Transplantation: A Clinical-Pathological Study of Autopsy Cases

✍ Kazushige Watanabe; Hiroyuki Iwaki; Masaaki Satoh; Tatsuru Ikeda; Shingo Ichimiy 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 715 KB

Transjugular intrahepatic portosystemic

Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation

✍ D. Azoulay; D. Castaing; A. Lemoine; G. Marin Hargeaves; H. Bismuth 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Recombinant tissue plasminogen activator

Recombinant tissue plasminogen activator (rt-PA) for veno-occlusive liver disease in pediatric autologous bone marrow transplant patients

✍ Dr. Lolie C. Yu; Indrani Malkani; Oswaldo Regueira; David L. Ode; Raj P. Warrier 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB 👁 2 views

Use of prostaglandin E1 for prevention o

Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation

✍ E. Gluckman; I. Jolivet; M. L. Scrobohaci; A. Devergie; R. Traineau; H. Bourdeau 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 512 KB